Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 529,997 | 444,568 | 471,884 | 382,805 | 177,519 |
| Marketable Securities | 211,636 | 300,286 | 364,074 | 180,599 | 187,193 |
| Receivables | 112,500 | N/A | N/A | N/A | N/A |
| Other current assets | 112,500 | 0 | 0 | 0 | 0 |
| TOTAL | $993,114 | $772,365 | $849,572 | $578,761 | $377,541 |
| Non-Current Assets | |||||
| PPE Net | 17,291 | 17,946 | 16,948 | 16,311 | 16,238 |
| Investments And Advances | 0 | 0 | 0 | 0 | 6,139 |
| Intangibles | 50,624 | 50,757 | 50,881 | 52,019 | 52,325 |
| Other Non-Current Assets | 74,555 | 77,693 | 25,858 | 25,147 | 24,871 |
| TOTAL | $142,470 | $146,396 | $93,687 | $93,477 | $99,573 |
| Total Assets | $1,135,584 | $918,761 | $943,259 | $672,238 | $477,114 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,701 | 5,077 | 6,796 | 4,382 | 18,768 |
| Accrued Expenses | 70,069 | 76,936 | 44,339 | 38,560 | 21,918 |
| Other current liabilities | 24,400 | 10,600 | 20,300 | 4,700 | 10,700 |
| TOTAL | $361,099 | $99,064 | $76,998 | $54,940 | $56,396 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 262,929 | 6,451 | 5,563 | 7,298 | 5,010 |
| Other Non-Current Liabilities | 116,466 | 95,777 | 46,786 | 46,399 | 30,518 |
| TOTAL | $123,534 | $102,845 | $53,906 | $53,519 | $40,385 |
| Total Liabilities | $484,633 | $201,909 | $130,904 | $108,459 | $96,781 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 130,040 | 127,837 | 127,389 | 127,055 | 117,902 |
| Common Shares | 13 | 13 | 13 | 12 | 11 |
| Retained earnings | -836,095 | -667,184 | -561,535 | -476,926 | -445,759 |
| Other shareholders' equity | -1,304 | -1,278 | -485 | -295 | 248 |
| TOTAL | $650,951 | $716,852 | $812,355 | $563,779 | $380,333 |
| Total Liabilities And Equity | $1,135,584 | $918,761 | $943,259 | $672,238 | $477,114 |